According to the Zhitong Finance App, Kangtai Medical (300869.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 354 million yuan, an increase of 2.83% over the previous year. Net loss attributable to shareholders of listed companies was RMB 57.282,500. The net loss of non-recurring profit and loss attributable to shareholders of the listed company was $685.151 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.